The project aims to establish an integrated Design–Make–Test–Analyze (DMTA) platform combining generative AI, ultra-large synthetically accessible chemical spaces, physics-informed molecular representations, off-target prediction, and experimental feedback. The developed methods will be applied in iterative prospective drug-discovery cycles, with a serine protease from the complement system serving as a real-world lead-optimization case study.
The successful candidate will play a central role in the computational and AI components of the project and work closely with our international and industrial project partners.